Infinium Global Research has added a new report on Type 1 Diabetes Drugs Market. The report presents analysis of global as well as regional markets of type 1 diabetes drugs market over the period of 2018 to 2024.
The Type 1 diabetes drugs are used to treat the type 1 diabetic disease, and are also known as Type 1 diabetes mellitus. Type 1 diabetes is a condition where in pancreas produce very little or no insulin at all. Insulin is a hormone that allows sugar (glucose) to enter cells to produce energy. People suffering from type 1 diabetes have to take daily insulin injection to keep body glucose in normal range. Without insulin injection, patient may die. In type 1 diabetes condition, body’s immune system attacks & destroy most of the beta cells in the pancreas. Different factors, including genetics and some viruses, may contribute to type 1 diabetes. Although type 1 diabetes usually appears during childhood or adolescence, however it can also develop in adults.
Growing occurrence of the type 1 diabetes is the major factor driving the type 1 diabetes drugs market. The rising awareness about the type 1 diabetes and availability of its treatment drugs, introduction of new advanced insulin delivery devices such as pumps & pens and improved drug delivery system is expected to boost the growth of the type 1 diabetes drug market over the forecast period. However, high cost of insulin delivery systems, especially insulin pump and autoinjector may act as a restraint to market growth. Moreover, the ongoing innovations in the diabetes drugs and the drug delivery system are projected to create the several opportunities in upcoming years.
Among the region, North America is dominating the type 1 diabetes drugs market owing to the high occurrence of diabetes among the population and adoption of new innovative insulin delivery systems such as insulin pumps are the major factors that are driving the North America region. The rapidly growing aging population and improved healthcare infrastructure in the Asia pacific region is likely to help to grow Asia Pacific region at the highest CAGR, during the forecast period
Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global type 1 diabetes drugs market but also make strategic decisions to capture the most lucrative markets in the near future. The market size is presented in terms of value for the historic year 2016 and estimated for forecast period of 2018-2024.
Get 15% discount for early purchase of global type 1 diabetes drugs market report by clicking the following link, Use code IGRD15 to request the discount in the given form
https://www.infiniumglobalresearch.com/reports/request-discount/1343
The recent report identified that dominated the global type 1 diabetes drugs market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the type 1 diabetes drugs market worldwide.
The report segments the global type 1 diabetes drugs market on the basis of Type and End User.
Global Type 1 Diabetes Drugs Market by Type
· Insulins
· Others
Global Type 1 Diabetes Drugs Market by End User
· Hospital
· Drugstore
· Others
Companies Profiled in the Report
· Eli Lilly and Company
· Novo Nordisk A/S
· XOMA Corp.
· Biodel, Inc.
· B.Braun Melsungen AG
· Astrazeneca Plc.
· DiaVacs, Inc.
· Biodel, Inc.
· Macrogenics, Inc.
About Infinium Global Research
Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.
Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.
